Dear Vin,,
Sometimes the truth is inconvient. My revelation about the dicconnect between the way the drug industry brings drugs to the market and how it serves to exclude GTC's platform is a repeat message first posted more than a year ago. Long before I ever sold a share of GTC. The reason I keep posting it is because well meaning posters like you, repeatedly either ignored it, disbelieved it, or did not understand its importance.
I guess it is easier just to blame Cox and management for the company's lack of suitors or go on believing it was just because BP thought the FDA would never give them a shot. Funny thing is when the EMEA decision was pending in 2006, there was not one long on the board who was sugesting the EMEA approval was not a huge deal, as the revisionists on this board are exclaiming. We all were convinced BP would be waiting in line to employ GTC. Never happened.
I'm still a fan of the company, but I'm more a fan of the technology. I sold my shares on the run up to the FDA decision. The reason is if the PPS falls back I will not be able to establish a position in the company who controls the technology. If that company is GTC because they get a big contract for an FOB, or get taken over or merge with another company, I will be buying back in. I have also posted I feel the technology will eventually be worth billions. My worst fear is LFB will end up with the technology and we will all be shut out.
regards JL